Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Fox-Geen JeremyChief Financial Officer | Option exercise · 10b5-1 plan | M | — 14.4K sh | Dec 16, 2025 |
| 0 | Cohlhepp RyanDirector, President and COO | Option exercise · 10b5-1 plan | M | — 8,000 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Cohlhepp RyanDirector, President and COO | Option exercise · 10b5-1 plan | M | $30K 8,000 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Disposition to issuer · 10b5-1 plan | D | — 500.0K sh | Dec 16, 2025 traded Dec 16, 2025 |
| 0 | Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER | Option exercise · 10b5-1 plan | M | — 506.0K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 0 | Gan HongCHIEF SCIENCE OFFICER | Option exercise · 10b5-1 plan | M | — 6,723 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Neville Patrick SeanDirector | Option exercise · 10b5-1 plan | M | — 30.0K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 0 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 166.7K sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Coddington Elizabeth FChief Financial Officer | Option exercise · 10b5-1 plan | M | — 21.8K sh | Dec 16, 2025 traded Dec 13, 2025 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Disposition to issuer · 10b5-1 plan | D | — 500.0K sh | Dec 16, 2025 traded Dec 16, 2025 |
| 0 | Ellenbogen MichaelDirector | Option exercise · 10b5-1 plan | M | $19K 80.7K sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Neville Patrick SeanDirector | Derivative conversion · 10b5-1 plan | C | — 30.0K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 0 | Neville Patrick SeanDirector | Derivative conversion · 10b5-1 plan | C | — 30.0K sh | Dec 16, 2025 traded Dec 12, 2025 |
| 0 | Neville Patrick SeanDirector | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Dec 16, 2025 traded Dec 12, 2025 |
| 0 | Gan HongCHIEF SCIENCE OFFICER | Option exercise · 10b5-1 plan | M | $14K 93.3K sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Disposition to issuer · 10b5-1 plan | D | — 500.0K sh | Dec 16, 2025 traded Dec 16, 2025 |
| 0 | Gan HongCHIEF SCIENCE OFFICER | Option exercise · 10b5-1 plan | M | $1,076 6,723 sh | Dec 16, 2025 traded Dec 15, 2025 |
| 0 | Glazer David A.See Remarks | Option exercise · 10b5-1 plan | M | — 9,000 sh | Dec 16, 2025 traded Dec 12, 2025 |
| 0 | Glazer David A.See Remarks | Gift · 10b5-1 plan | G | — 3,831 sh | Dec 16, 2025 traded Dec 12, 2025 |
| 56 | Fortunato DavidDirector, CEO and President | Open-market sale | SELL | $10.71M 765.2K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 53 | Fortunato DavidDirector, CEO and President | Open-market sale | SELL | $1.34M 95.4K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 53 | Imberman AlanCFO and Treasurer | Open-market sale | SELL | $1.40M 100.0K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 53 | Wetterwald JulienChief Technology Officer | Open-market sale | SELL | $1.68M 120.0K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 51 | Bisharat JalehDirector | Open-market sale | SELL | $140K 10.0K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 50 | Lin LaurenCLO, CCO and Secretary | Open-market sale | SELL | $423K 30.2K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 49 | Usen ToddDirector, Chief Executive Officer | Open-market purchase | BUY | $226K 207.3K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 48 | March Stanley RaymondVP, Corporate Development | Open-market sale | SELL | $1,029 158 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Miller Austin ScottDirector | Open-market sale | SELL | $33K 5,051 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Botti JeanDirector | Open-market sale | SELL | $33K 5,051 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | March Stanley RaymondVP, Corporate Development | Open-market sale | SELL | $690 106 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Anderson Joshua JosephChief Technology Officer | Open-market sale | SELL | $1,074 165 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 48 | Anderson Joshua JosephChief Technology Officer | Open-market sale | SELL | $716 110 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 46 | Schwartz DebraDirector | Open-market sale | SELL | $351K 4,200 sh | Dec 15, 2025 traded Dec 11, 2025 |
| 45 | GSK plc10% Owner | Open-market purchase | BUY | $27.93M 1.47M sh | Dec 15, 2025 traded Dec 11, 2025 |
| 42 | Turner Timothy WilliamDirector, Chief Executive Officer | Open-market sale | SELL | $6.95M 129.6K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 40 | March Stanley RaymondVP, Corporate Development | Open-market sale | SELL | $130 20 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 40 | Anderson Joshua JosephChief Technology Officer | Open-market sale | SELL | $137 21 sh | Dec 15, 2025 traded Dec 15, 2025 |
| 40 | Bar-Zeev TomerDirector | Open-market sale | SELL | $4.37M 86.4K sh | Dec 15, 2025 traded Dec 11, 2025 |
| 40 | Bar-Zeev TomerDirector | Open-market sale | SELL | $2.35M 50.0K sh | Dec 15, 2025 traded Dec 12, 2025 |
| 39 | Imberman AlanCFO and Treasurer | Option exercise | M | $98K 40.0K sh | Dec 15, 2025 traded Sep 5, 2025 |